OlegEAkilovMDPhD

PubMed

• Unleashed monocytic engagement in Sézary syndrome during the combination of anti-CCR4 antibody with type I interferon.
  Tony T Jiang, Oleg Kruglov, Oleg E Akilov> ;Blood Advances. 2024 Mar 15
• Utility of Low-Dose Duvelisib for Advanced Mycosis Fungoides: A Single-Institution Study.
  Verardi, N., Bazewicz, C., Akilov, O.> ;The Oncologist. 2024 Mar 4
• 1 citations
  Deciphering Tumor Cell Evolution in Cutaneous T-Cell Lymphomas: Distinct Differentiation Trajectories in Mycosis Fungoides and Sézary Syndrome.
  Tony T Jiang, Simon Cao, Oleg Kruglov, Aman Virmani, Larisa J Geskin, Louis D Falo Jr, Oleg E Akilov> ;The Journal of Investigative Dermatology. 2023 Nov 28
• What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?
  Oleg E Akilov> ;Cells. 2023 Sep 20
• CD5+ Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, Presenting as an Asymptomatic Nodule.
  Amy Xiao, Colleen J Beatty, Sonal Choudhary, Oleg E Akilov> ;Hematology Reports. 2023 Sep 1
• Hydroxychloroquine for the treatment of hidradenitis suppurativa.
  Elena Gonzalez Brant, Oleg Akilov> ;JAAD Case Reports. 2023 Jul 1
• Factors associated with disease-specific life impact in patients with hidradenitis suppurativa: results from the Global VOICE project.
  Garg, A., Rawal, S., Akilov, O., Alavi, A., Ardon, C., Bechara, F., Cohen, A., Cohen, S., Daveluy, S., Del Marmol, V., Delage, M., Esmann, S., Fisher, S., Giamarellos-...> ;The British Journal of Dermatology. 2023 May 24
• 2 citations
  Blockade of the Immune Checkpoint CD47 by TTI-621 Potentiates the Response to Anti-PD-L1 in Cutaneous T-Cell Lymphoma.
  Zhen Han, Xiwei Wu, Hanjun Qin, Yate-Ching Yuan, Jasmine Zain, D Lynne Smith, Oleg E Akilov, Steven T Rosen, Mingye Feng, Christiane Querfeld> ;The Journal of Investigative Dermatology. 2023 Aug 1
• 1 citations
  Pseudolymphoma of the nipple treated with topical imiquimod and cryotherapy.
  Amy Xiao, John D Miedler, Oleg E Akilov> ;JAAD Case Reports. 2022 Dec 1
• 5 citations
  Targeting the CD47-SIRPα Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma.
  Amy Xiao, Oleg E Akilov> ;Cells. 2022 Nov 13
• International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective co...
  Larisa J Geskin, Bradley D Kwinta, Tiffany J Garcia-Saleem, Oleg E Akilov, Paula A Enz, Emmanuella Guenova, Pablo L Ortiz-Romero, Evangelia Papadavid, Pietro Quaglino,...> ;Journal of the American Academy of Dermatology. 2023 Apr 1
• TCL-458 Real-World Treatment Patterns in Patients With Sézary Syndrome in the United States and the Impact of Covid-19.
  Yang Zhao, Jackson Tang, Huanxue Zhou, Takeshi Takahashi, Takanobu Nomura, Eslie Dennis, Oleg Akilov> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Oct 1
• 1 citations
  CD8+ T Lymphocytes in Hypopigmented Mycosis Fungoides: Malignant Cells or Reactive Clone?
  Simon Cao, Oleg Kruglov, Oleg E Akilov> ;The Journal of Investigative Dermatology. 2023 Mar 1
• 1 citations
  Repetitive expanded T-cell receptor clonotypes impart the classic T helper 2 Sézary cell phenotype.
  Tony T Jiang, Oleg Kruglov, Larisa Geskin, Oleg E Akilov> ;The British Journal of Dermatology. 2022 Aug 1
• 2 citations
  Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project.
  Bria Midgette, Andrew Strunk, Oleg Akilov, Afsaneh Alavi, Christine Ardon, Falk G Bechara, Arnon D Cohen, Steven Cohen, Steven Daveluy, Véronique Del Marmol, Maïa Dela...> ;The British Journal of Dermatology. 2022 Dec 1
• 15 citations
  Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial.
  Ellen J Kim, Aaron R Mangold, Jennifer A DeSimone, Henry K Wong, Lucia Seminario-Vidal, Joan Guitart, James Appel, Larisa Geskin, Edward Lain, Neil J Korman, Nathalie ...> ;JAMA Dermatology. 2022 Sep 1
• Correction to: The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides ...
  Ellen J Kim, Joan Guitart, Christiane Querfeld, Michael Girardi, Amy Musiek, Oleg E Akilov, James T Angello, William L Bailey, Larisa J Geskin> ;American Journal of Clinical Dermatology. 2022 May 1
• Exhausted Markers in Cutaneous T-Cell Lymphoma: The Face that Launched a Thousand Ships.
  Tony T Jiang, Oleg E Akilov> ;The Journal of Investigative Dermatology. 2022 Mar 1
• 6 citations
  Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma.
  Raman Preet Kaur Gill, Jennifer Gantchev, Amelia Martínez Villarreal, Brandon Ramchatesingh, Elena Netchiporouk, Oleg E Akilov, Niels Ødum, Robert Gniadecki, Sergei B ...> ;Cells. 2022 Feb 9
• 2 citations
  Effective treatment of mogamulizumab-induced head and neck dermatitis with fluconazole in a patient with peripheral T-cell lymphoma.
  Ishan Asokan, Sanminder Singh, John Moesch, Jonhan Ho, Oleg E Akilov> ;JAAD Case Reports. 2022 Feb 1
• 5 citations
  Clinical Response to Anti-CD47 Immunotherapy Is Associated with Rapid Reduction of Exhausted Bystander CD4+ BTLA+ T Cells in Tumor Microenvironment of Mycosis Fungoides
  Tony T. Jiang, Oleg Kruglov, Gloria H. Y. Lin, Angela Minic, Kimberly R. Jordan, Robert A. Uger, Mark Wong, Yaping Shou, Oleg E. Akilov> ;Cancers. 2021 Nov 28
• Research Techniques Made Simple: Skin-Targeted Drug and Vaccine Delivery Using Dissolvable Microneedle Arrays.
  Stephen C. Balmert, Zohreh Gholizadeh Ghozloujeh, Cara Donahue Carey, Oleg E. Akilov, Emrullah Korkmaz, Louis D. Falo> ;The Journal of Investigative Dermatology. 2021 Nov 1
• 32 citations
  Intralesional TTI-621, a novel biologic targeting the innate immune checkpoint CD47, in patients with relapsed or refractory mycosis fungoides or Sézary syndrome: a mu...
  Christiane Querfeld, John A. Thompson, Matthew H. Taylor, Jennifer DeSimone, Jasmine Zain, Andrei R. Shustov, Carolyn Johns, Sue Ann McCann, Gloria H. Y. Lin, Penka S....> ;The Lancet. Haematology. 2021 Oct 7
• 4 citations
  The pivotal role of cytotoxic NK cells in mediating the therapeutic effect of anti-CD47 therapy in mycosis fungoides
  Oleg Kruglov, Lisa Johnson, Angela Minic, Kimberly R. Jordan, Robert A. Uger, Mark Wong, Eric L. Sievers, Yaping Shou, Oleg E. Akilov> ;Cancer Immunology, Immunotherapy. 2021 Sep 14
• 39 citations
  Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data
  Steven M. Horwitz, Julia Scarisbrick, Reinhard Dummer, Sean Whittaker, Madeleine Duvic, Youn H. Kim, Pietro Quaglino, Pier Luigi Zinzani, Oliver Bechter, Herbert Erada...> ;Blood Advances. 2021 Sep 10
• Join now to see all

Lectures

• Superior Clinical Benefit of Brentuximab Vedotin in Mycosis Fungoides Versus Physician's Choice Irrespective of CD30 Level or Large Cell Transformation Status in the P... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Intralesional Administration of the CD47 Antagonist TTI-621 (SIRPαFc) Induces Responses in Both Injected and Non-Injected Lesions in Patients with Relapsed/Refractory ... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018